North Texas Clinical Trials

What North Texas Clinical Trials does

North Texas Clinical Trials is a stand-alone, privately held clinical research site (LLC) founded in 2012 and headquartered at 1650 W Rosedale St, Suite 300 in Fort Worth, Texas. The company conducts Phase I through Phase IV pharmaceutical drug, medication, and device clinical trials on behalf of pharmaceutical sponsors, serving patients across the Dallas-Fort Worth metroplex. Its current enrollment portfolio spans more than a dozen therapeutic areas including Women's Health, Immunology, Cardiology, Dermatology, Neurology, Internal Medicine, Psychiatry, and Rare Disease, with active studies in conditions such as Major Depressive Disorder, Essential Tremor, Migraines, Bipolar Disorder, PTSD, OCD, Schizophrenia, Treatment Resistant Depression, Alzheimer's, and Generalized Anxiety Disorder.

The site operates in-house clinical infrastructure that includes a CLIA-certified laboratory, FDA 21 CFR Part 11 compliant electronic records and signature systems, HIPAA-compliant data handling, temperature-controlled secure IP storage, emergency medication, and calibrated equipment (blood pressure cuffs, ECG machines, centrifuges, -20 and -80 freezers). It also supports specialty procedures such as umbilical cord blood sampling and MRI, and claims a 24-hour data entry turnaround. Staff hold ACRP-CP, CCRC, SOCRA, and CPR/ACLS/PALS certifications, and the company maintains a dedicated regulatory department and in-house quality assurance and control program.

The business model is professional services revenue generated from pharmaceutical sponsors for clinical trial conduct. Patient recruitment is conducted direct-to-consumer via a 'Book Now' online scheduling system, 15-minute phone-based pre-screenings, online intake forms processed through IntakeQ, and social media channels (Facebook, LinkedIn, Instagram), with an email newsletter for ongoing engagement. Sponsor relationships are managed through direct enterprise sales. The company is independently owned with no parent company, no disclosed external funding, and no disclosed M&A or partnership activity; revenue is not publicly disclosed.

Name

North Texas Clinical Trials

Legal name

North Texas Clinical Trials, LLC

Website

https://ntxct.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

North Texas Clinical Trials is a stand-alone, privately held Phase I-IV clinical research site in Fort Worth, Texas that conducts medication and device trials on behalf of pharmaceutical sponsors and recruits patients across the Dallas-Fort Worth metroplex.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)

Keywords

• Clinical trial services
• Pharmaceutical drug trials
• Medical device trials
• Clinical research site
• Phase I-IV trials

Headquarters

HQ city

Fort Worth

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Clinical Trial Conduct Services: Revenue generated from conducting clinical trials on behalf of pharmaceutical sponsors. The company serves as a stand-alone clinical trials site providing research services for Phase I-IV studies across multiple therapeutic areas including medication and device trials.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

North Texas Clinical Trials is a stand-alone clinical research site that conducts Phase I through Phase IV medication and device trials on behalf of pharmaceutical, biotech, and medical device sponsors in the Dallas-Fort Worth metroplex. Services span multiple therapeutic areas (Women's Health, Immunology, Cardiology, Dermatology, Neurology, Internal Medicine, Psychiatry, and Rare Disease) and are delivered through dedicated subject recruitment, in-house regulatory and QA/QC, an on-site CLIA lab, FDA Part 11 and HIPAA compliant data systems, and certified clinical research staff. Patients of all ages are recruited to participate in active studies, and sponsors receive high-quality, rapidly turned-around clinical trial data.

Product overview

North Texas Clinical Trials operates as a stand-alone clinical research site offering a unified portfolio of Phase I-IV medication and device trials. The core service encompasses clinical trial conduct with dedicated subject recruitment, regulatory support, and quality assurance. The Current Studies Program lists active therapeutic areas (neurology, psychiatry, women's health, immunology, cardiology, dermatology, internal medicine, rare disease) with specific conditions currently enrolling participants. Services are delivered through in-house capabilities including a CLIA lab, calibrated equipment, emergency medication, and temperature-controlled secure IP storage.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase I-IV Clinical Trial Conduct Services Stand-alone clinical research site offering Phase I-IV medication and device trial execution for pharmaceutical, biotech, and medical device sponsors across multiple therapeutic areas; delivered with in-house regulatory, QA/QC, CLIA lab, and certified staff.
• Current Studies Program (Active Enrollment) Active enrollment offering for individuals to participate in currently recruiting clinical trials across neurology, psychiatry, women's health, and other therapeutic areas including Major Depressive Disorder, Essential Tremor, Migraines, Bipolar Disorder, PTSD, OCD, Schizophrenia, Treatment Resistant Depression, Perimenopausal Depression, Tourette Syndrome, Alzheimer's, and Generalized Anxiety Disorder.

Quantifiable outcome

• Patient safety as primary concern with well-informed clinical trial volunteers making best participants.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Parexel International: Large global CRO that runs its own site network and partners with independent sites like NTXCT. Represents both a potential sponsor-feeder and a competitive force in clinical trial operations.

Others

• Clincierge: Patient logistics and concierge services provider for clinical trial participants. Complementary to NTXCT's recruitment efforts rather than a direct competitor — useful ecosystem reference for patient-retention strategy.

Direct peers

• Flourish Research: Multi-site clinical research organization with therapeutic breadth in CNS, cardiology, and general medicine. Competes with NTXCT for sponsor feasibility placement and patient recruitment in overlapping metros.
• Velocity Clinical Research: Large multi-site SMO network conducting Phase I–IV trials across diverse therapeutic areas. Direct competitor for sponsor contracts, with the scale advantage of a PE-backed platform versus NTXCT's single-site footprint.
• CenExel Clinical Research: Therapeutic-focused SMO network with deep capabilities in CNS, analgesia, and specialty indications. Directly comparable to NTXCT in trial conduct, certification stack, and sponsor-facing value proposition.
• Accel Research Sites: Multi-therapeutic SMO network operating clinical trial sites across the US. Competes head-to-head with NTXCT on Phase II–IV trials in psychiatry, neurology, and general medicine indications.
• Optimal Research: Independent clinical research site organization running Phase I–IV trials in CNS, psychiatry, and general medicine. Closely comparable scale and service mix to NTXCT.
• Benchmark Research: Independent multi-site SMO with therapeutic overlap in psychiatry, neurology, and infectious disease. Direct competitor to NTXCT for sponsor Phase II–IV placement.

Emerging players

• HD Research: Independent multi-site clinical research organization with overlap in CNS and internal medicine trials. Similar scale and operational model to NTXCT, often pursuing the same sponsor relationships.
• Clinart Clinical Research: Independent clinical research site network conducting Phase II–IV studies. Comparable to NTXCT in operating model and therapeutic mix, with growing geographic footprint.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/NorthTexasClinicalTrials
• LinkedInlinkedin.com/company/north-texas-clinical-trials
• Instagraminstagram.com/ntxct.research
• Xx.com/ntxctfw

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about North Texas Clinical Trials